Gate 322 Lofibra 67 mg Pill - pink capsule/oblong, 14mm
Generic Name: fenofibrate
Pill with imprint Gate 322 Lofibra 67 mg is Pink, Capsule/Oblong and has been identified as Lofibra 67 mg. It is supplied by Gate Pharmaceuticals.
Lofibra is used in the treatment of Hypertriglyceridemia; Hyperlipoproteinemia Type IIa, Elevated LDL; Hyperlipoproteinemia Type IIb, Elevated LDL VLDL; Hyperlipoproteinemia; Hyperlipoproteinemia Type IV, Elevated VLDL and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 67 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Gate 322 Lofibra 67 mg
Lofibra
- Generic Name
- fenofibrate
- Imprint
- Gate 322 Lofibra 67 mg
- Strength
- 67 mg
- Color
- Pink
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gate Pharmaceuticals
- National Drug Code (NDC)
- 57844-0322 (Discontinued)
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
povidone k25,
corn starch,
sodium lauryl sulfate,
magnesium silicate,
D&C Red No. 28,
FD&C Blue No. 1,
FD&C Red No. 40,
titanium dioxide
Note: Inactive ingredients may vary.
More about Lofibra (fenofibrate)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: fibric acid derivatives
- Breastfeeding
Patient resources
Other brands
TriCor, Triglide, Lipofen, Antara, Fenoglide
Professional resources
Other brands
TriCor, Triglide, Lipofen, Antara, Fenoglide
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.